Tilray
TLRY
₹60.63
Share price
1.63%
Change (1 day)
-60.44%
Change (1 year)
Categories
Tilray (TLRY) - Cash on Hand
Cash on Hand as of February 2025 : ₹21.52 Billion
According to Tilray
's latest financial reports the company has ₹21.52 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Tilray - Cash on Hand chart (from 2021 to 2021)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-05-31 | ₹21.74 B | -41.37% |
| 2023-05-31 | ₹37.07 B | 14.89% |
| 2022-05-31 | ₹32.27 B | -8.85% |
| 2021-05-31 | ₹35.40 B | 79.13% |
| 2020-05-31 | ₹19.76 B | -9% |
| 2019-05-31 | ₹21.72 B | 412.99% |
| 2018-05-31 | ₹4.23 B | -28.67% |
| 2017-05-31 | ₹5.93 B | 814.13% |
| 2016-05-31 | ₹0.64 B | 123.65% |
| 2015-05-31 | ₹0.29 B | |
| 2014-08-31 | ₹9.35 M | -47.3% |
| 2013-08-31 | ₹17.75 M | -7.09% |
| 2012-08-31 | ₹19.11 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | ₹1.42 B | -93.40% | 🇺🇸 USA |
 OPKO Health
OPK | ₹37.77 B | 75.51% | 🇺🇸 USA |